GASMOTIN Side Effects

6574911-5 | Clonic Convulsion, Hypoglycaemia
on Jan 29, 2010 Male patient from JAPAN , weighting 119.0 lb, was diagnosed with gastrointestinal disorder postoperative, nutritional condition abnormal, pancreatic insufficiency, gastric ulcer, diabetes mellitus, cholangitis and was treated with Gasmotin (View Usage). Patient experienced the following unwanted or unexpected effects: clonic convulsion, hypoglycaemia. Gasmotin dosage: Daily Dose: 15 Milligram(s). During the same period patient was treated with CREON (Daily Dose: 12 Dosage Form, As Used: After Lunch) (View Creon Review and Creon Label ), URSO 250 (Daily Dose: 300 Milligram(s)) (View Urso 250 Review and Urso 250 Label ), PARIET (Daily Dose: 10 Milligram(s)) (View Pariet Review and Pariet Label ), HUMALOG (Daily Dose: 22-36 Iu, As Used: 2-12 Iu, Frequency: 3 Times A Day; Humalog Kit) (View Humalog Review and Humalog Label ), LANTUS (Daily Dose: 8 International Unit(s), Frequency: 0-1 Time A Day) (View Lantus Review and Lantus Label ), FLOMOX (Daily Dose: 200 Milligram(s)) (View Flomox Review and Flomox Label ). Patient was hospitalized.

5706191-4 | Delirium
Patient was taking Gasmotin (View Usage). Patient had the following side effects: delirium on Apr 03, 2008 from JAPAN Additional patient health information: Male patient , 84 years of age, . Gasmotin dosage: Unk. During the same period patient was treated with MYSLEE (View Myslee Review and Myslee Label ).

5649538-X | Delirium
Adverse event was reported on Feb 26, 2008 by a Male patient taking Gasmotin (View Usage) (Dosage: Unk) . Location: JAPAN , 84 years of age, After Gasmotin was administered, patient had the following side effects: delirium. During the same period patient was treated with MYSLEE (View Myslee Review and Myslee Label ).

5233497-8 | Convulsion, Depressed Level Of Consciousness
on Jan 26, 2007 Male patient from JAPAN , 33 years of age, was diagnosed with gastritis, suicide attempt, insomnia and was treated with Gasmotin (View Usage). Patient experienced the following unwanted or unexpected effects: convulsion, depressed level of consciousness. Gasmotin dosage: . During the same period patient was treated with GOODMIN (1 Unit) (View Goodmin Review and Goodmin Label ), MEILAX (1 Mg) (View Meilax Review and Meilax Label ).


5226552-X | Convulsion, Depressed Level Of Consciousness
on Jan 26, 2007 Male patient from JAPAN , 33 years of age, was diagnosed with gastritis, suicide attempt, insomnia and was treated with Gasmotin (View Usage). Patient had the following side effects: convulsion, depressed level of consciousness. Gasmotin dosage: . During the same period patient was treated with GOODMIN (1 Unit) (View Goodmin Review and Goodmin Label ), MEILAX (1 Mg) (View Meilax Review and Meilax Label ).

5199990-1 | Convulsion, Depressed Level Of Consciousness
Patient was taking Gasmotin (View Usage). After Gasmotin was administered, patient had the following side effects: convulsion, depressed level of consciousness on Dec 27, 2006 from JAPAN Additional patient health information: Male patient , 33 years of age, . Gasmotin dosage: Unk. During the same period patient was treated with GOODMIN (1 Unit) (View Goodmin Review and Goodmin Label ), LUVOX (Unk) (View Luvox Review and Luvox Label ).

4819036-1 | Blood Corticotrophin Increased, Blood Cortisol Increased
Adverse event was reported on Nov 01, 2005 by a Male patient taking Gasmotin (View Usage) (Dosage: Daily Dose: 3 Dosage Form) was diagnosed with ill-defined disorder, depression (What is depression?) and. Location: JAPAN , 82 years of age, Patient experienced the following unwanted or unexpected effects: blood corticotrophin increased, blood cortisol increased. During the same period patient was treated with LUVOX (Daily Dose: 50 Milligram(s)) (View Luvox Review and Luvox Label ), HALFDIGOXIN (Daily Dose: .5 Dosage Form) (View Halfdigoxin Review and Halfdigoxin Label ), ALOSENN (Daily Dose: 2 Gram(s)) (View Alosenn Review and Alosenn Label ), BERIZYM (Daily Dose: 1.2 Gram(s)) (View Berizym Review and Berizym Label ), LAC B (Daily Dose: 3 Gram(s)) (View Lac B Review and Lac B Label ), FOIPAN (Daily Dose: 3 Dosage Form) (View Foipan Review and Foipan Label ).

4718507-6 | Dermatitis, Haemoglobin Decreased, Hepatic Encephalopathy, Intra-abdominal Haemorrhage, Lip Erosion, Malignant Neoplasm Progression, Oedema, Pruritus, Pyrexia
on Oct 23, 2002 Male patient from JAPAN , 53 years of age, weighting 167.6 lb, was diagnosed with gastrointestinal stromal tumour and was treated with Gasmotin (View Usage). Patient had the following side effects: dermatitis, haemoglobin decreased, hepatic encephalopathy, intra-abdominal haemorrhage, lip erosion, malignant neoplasm progression, oedema, pruritus, pyrexia. Gasmotin dosage: . During the same period patient was treated with MAGNESIUM OXIDE (View Magnesium Oxide Review and Magnesium Oxide Label ), LENDORMIN (View Lendormin Review and Lendormin Label ), LUDIOMIL (View Ludiomil Review and Ludiomil Label ), TORSEMIDE (View Torsemide Review and Torsemide Label ), GLEEVEC (300 Mg, Qd) (View Gleevec Review and Gleevec Label ). Patient was hospitalized.

4656377-5 | Hypoaesthesia, Rhabdomyolysis
on May 10, 2004 Male patient from , 76 years of age, was diagnosed with gastric ulcer, hyperlipidaemia, thrombolysis, prophylaxis, myocardial infarction and was treated with Gasmotin (View Usage). After Gasmotin was administered, patient had the following side effects: hypoaesthesia, rhabdomyolysis. Gasmotin dosage: . During the same period patient was treated with ZOCOR (View Zocor Review and Zocor Label ), WARFARIN POTASSIUM (View Warfarin Potassium Review and Warfarin Potassium Label ), ISOSORBIDE DINITRATE (View Isosorbide Dinitrate Review and Isosorbide Dinitrate Label ), FAMOTIDINE (View Famotidine Review and Famotidine Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), VASOTEC (View Vasotec Review and Vasotec Label ), PERSANTIN (View Persantin Review and Persantin Label ). Patient was hospitalized.

4586507-5 | Blood Glucose Increased, Blood Potassium Increased, Blood Sodium Decreased, Cardio-respiratory Arrest, Haematocrit Decreased, Haemoglobin Increased, Hepatic Failure, Hepatitis, Platelet Count Decreased
Patient was taking Gasmotin (View Usage). Patient experienced the following unwanted or unexpected effects: blood glucose increased, blood potassium increased, blood sodium decreased, cardio-respiratory arrest, haematocrit decreased, haemoglobin increased, hepatic failure, hepatitis (What is hepatitis?), platelet count decreased on Aug 26, 2004 from Additional patient health information: Male patient , weighting 143.3 lb, was diagnosed with prophylaxis, depression (What is depression?), anxiety (What is anxiety?), insomnia and. Gasmotin dosage: Daily Dose: 15 Milligram(s). During the same period patient was treated with DEPROMEL 25 (Daily Dose: 50 Milligram(s)) (View Depromel 25 Review and Depromel 25 Label ), LEXOTAN (Daily Dose: 6 Milligram(s)) (View Lexotan Review and Lexotan Label ), EURODIN (Daily Dose: 2 Milligram(s)) (View Eurodin Review and Eurodin Label ). Patient was hospitalized.

4566263-7 | Cardio-respiratory Arrest, Haematocrit Decreased, Haemoglobin Decreased, Hepatic Failure, Hepatitis, Platelet Count Decreased, Red Blood Cell Count Decreased, Swelling
Adverse event was reported on Aug 26, 2004 by a Male patient taking Gasmotin (View Usage) (Dosage: Daily Dose: 15 Milligram(s)) was diagnosed with prophylaxis, depression (What is depression?), anxiety (What is anxiety?), insomnia and. Location: , weighting 143.3 lb, Patient had the following side effects: cardio-respiratory arrest, haematocrit decreased, haemoglobin decreased, hepatic failure, hepatitis (What is hepatitis?), platelet count decreased, red blood cell count decreased, swelling. During the same period patient was treated with FLUVOXAMINE MALEATE (Daily Dose: 50 Milligram(s)) (View Fluvoxamine Maleate Review and Fluvoxamine Maleate Label ), LEXOTAN (Daily Dose: 6 Milligram(s)) (View Lexotan Review and Lexotan Label ), EURODIN (Daily Dose: 2 Milligram(s)) (View Eurodin Review and Eurodin Label ). Patient was hospitalized.